AN2 Therapeutics Promotes Joshua Eizen to Key Roles
Company Announcements

AN2 Therapeutics Promotes Joshua Eizen to Key Roles

AN2 Therapeutics, Inc. ( (ANTX) ) has shared an announcement.

AN2 Therapeutics has promoted its Chief Legal Counsel, Joshua Eizen, to the roles of Chief Legal Officer and Chief Operating Officer, effective immediately. Eizen’s new compensation package includes a salary of $450,000, stock options, and restricted stock units that vest over time. This move is part of AN2’s strategic efforts to strengthen its leadership team, appealing to investors looking at executive management changes.

See more data about ANTX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAN2 Therapeutics gets continuation grant to discover novel boron based therapies
TheFlyAN2 Therapeutics adopts limited duration stockholder rights plan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App